Article Details
Retrieved on: 2021-10-28 05:00:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Two monoclonal antibodies directed toward different interleukin (IL) targets produced wildly different results in randomized phase II trials ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here